# Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeting-cd20-in-primary-membranous-nephropathy-serologically-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Huiling Cao,Yu-Mei Feng,Xueting Li,Ben Ke,Limin Gong |
| Citations | 2 |
| DOI | 10.2147/dddt.s560746 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.dovepress.com/article/download/108669 |
| OpenAlex ID | https://openalex.org/W4415965453 |
| PMID | 41229922 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Huiling Cao](https://scholariq.org/researchers/huiling-cao/)
- [Yu-Mei Feng](https://scholariq.org/researchers/yu-mei-feng/)
- [Ben Ke](https://scholariq.org/researchers/ben-ke/)
- [Xueting Li](https://scholariq.org/researchers/xueting-li/)
- [Limin Gong](https://scholariq.org/researchers/limin-gong/)

## Paper funders

- [National Natural Science Foundation of China](https://scholariq.org/funders/national-natural-science-foundation-of-china/)

## Paper journal

- [Drug Design Development and Therapy](https://scholariq.org/journals/drug-design-development-and-therapy/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.